Shock Wave Therapy for Horses: Clinical Evidence for Lameness and Injury Treatment
Eighty-one percent of chronically lame horses unresponsive to conventional navicular treatment improved with shock wave therapy—and stayed sound beyond 12 months.Â
That’s Dr. McClure’s peer-reviewed research, one of several studies Dr. Kim Keeton shared in her recent Zomedica webinar on equine shock wave therapy using PulseVet technology. Dr. Keeton brings 20 years of equine veterinary experience and 15+ years using PulseVet shock wave technology to her integrative practice outside Athens, Georgia.Â
Why Electrohydraulic Technology Matters in Equine Shock Wave Therapy
PulseVet shock wave therapy deposits acoustic energy where tissue density changes—tendon-to-bone attachments, joint capsules, bone interfaces—triggering cytokine release that increases blood flow, stimulates neovascularization, and returns chronic conditions to an acute healing phase.Â
The focal zone comparison:Â
- PulseVet’s electrohydraulic system: 140,000 mm³ tissue affected per pulseÂ
- Electromagnetic devices: 61,000 mm³Â
- Piezoelectric (linear trode): 2,476 mm³Â
Translation: You cover more tissue with fewer pulses. That means 1-3 treatments every 2-3 weeks instead of 4-8 weekly sessions required by piezoelectric systems.Â
Dr. Keeton’s clinical pearl: “If you can see it on ultrasound, you can treat it with PulseVet shock wave therapy. Both use sound energy.”Â
Shock Wave Therapy for Navicular Syndrome: 81% Improvement Rate
Dr. McClure’s study enrolled chronically lame horses that had already failed conventional treatment. These weren’t mild cases. Â
Protocol: 2,000 pulses—1,000 through the frog, 1,000 through heel bulbs at E6 energyÂ
Results: 81% showed decreased lameness with no relapse beyond 12 months.Â
Practice implication: You can offer clients a non-invasive alternative to neurectomy for one of equine medicine’s most frustrating chronic conditions. Zero complications reported across the study population.Â
Tendon Injuries: Quality Matters More Than Speed
A 10-horse study (each horse serving as its own control) with collagenase-induced tendonitis demonstrated what Dr. Keeton calls the critical factor: PulseVet shock wave therapy improved the quality of tendon repair, not just healing speed.Â
For performance horses, that quality differential determines reinjury risk. Suspensory ligament studies backed this up with measurable improvements in fiber alignment scores and echogenicity on ultrasound.Â
Standard protocol: Three treatments at 3-week intervals. Â
This makes equine shock wave therapy particularly valuable for sport horses where quality of repair determines return to competition.Â
Osteoarthritis: Better Than Adequan in Head-to-Head Study
The 2009 carpal OA study compared three groups: placebo, polysulfated glycosaminoglycans (standard Adequan protocol: 7 doses over 28 days), and PulseVet shock wave therapy.Â
Horses treated with PulseVet therapy showed significantly greater lameness improvement than both other groups.Â
An earlier hock study (74 horses with tarsometatarsal and distal intertarsal OA) delivered 80% improvement rates:Â
- 38% improved one lameness gradeÂ
- 42% improved two gradesÂ
- Single treatment of 1,000-2,000 pulsesÂ
Back Pain: 89% Success Rate, 3-5 Day Return to Work
“Rest does not help a chronic sore back heal,” Dr. Keeton stated bluntly, drawing the parallel to veterinarians’ own back pain experience.Â
A 74-horse retrospective on PulseVet shock wave therapy for kissing spines and dorsal articular process inflammation showed 89% positive outcomes, with 60% maintaining improvement for 4-6 months.Â
Why this matters mid-season: Horses rest just 2 days post-treatment, return gradually over 3-5 days. Your performance horse clients don’t lose weeks of competition preparation.Â
Protocol: 2,000 pulses, single treatment using 35mm trode (midline for spinous processes) and 80mm trode (oblique angle for deeper dorsal articular processes)Â
Wounds: When Everything Else Fails
Dr. Keeton presented “Doodlebug,” a 5-year-old Quarter Horse mare with biopsy-confirmed habronemiasis persisting over one year despite multiple surgical debridements, ivermectin, moxidectin, corticosteroids, and topical treatments.Â
Dr. Hugh Worsham (Cumming, Georgia) administered two PulseVet shock wave treatments three days apart—just 500 pulses with the 5mm trode at lowest energy.Â
The summer sore completely healed.Â
Another case: a 6-month-old miniature horse with dog attack wounds, suspected clostridial infection, progressive necrosis, and copious purulent discharge. Three PulseVet shock wave treatments (days 5, 8, and 11 post-attack) produced substantial healing by day 32.Â
The mechanism behind equine shock wave therapy for wounds: Increased blood flow enhances antibiotic penetration. Biofilm disruption tackles resistant infections. Cytokine release (VEGF, TGF-β, PCNA) drives neovascularization.Â
Exercise-Induced Pulmonary Hemorrhage: Treating EIPH with Shock Wave Therapy
Dr. Beau Whitaker’s barrel racing study represents what Dr. Keeton called “one of the most exciting things coming out of PulseVet shock wave therapy”—treating exercise-induced pulmonary hemorrhage.Â
Study: 21 barrel racers (13 had bled at their last race, 9 competed on Lasix)Â
Results:Â
- Average BAL score dropped 1.5 gradesÂ
- 76% improved one grade minimumÂ
- 47% improved two gradesÂ
The insight: All horses had underlying equine asthma. The theory suggests asthma causes EIPH—PulseVet shock wave therapy addresses root pathology, not just symptoms.Â
Research on PulseVet therapy for equine asthma is being extended through a Clinical Registry for Equine Asthma.Â
Amplifying Your Orthobiologic Protocols
If you’re already using regenerative medicine in your equine practice, PulseVet shock wave therapy enhances results:Â
PRP study findings: Shock wave application increased growth factor expression by 33-46% (TGF-β) and 190-219% (PDGF-ββ) compared to controls.Â
Stem cell research: 500 pulses at low energy doesn’t damage mesenchymal stem cell proliferation or differentiation. Day-3 post-treatment showed increased ALPL indicating osteogenic effects potentially beneficial for fracture healing.Â
Treatment Duration Reality
Dr. Keeton addressed the chronic condition question directly: Effects typically last 4-12 months before potential retreatment. This makes PulseVet shock wave therapy appropriate for long-term management, not just acute intervention.Â
Why Major Equine Organizations Choose PulseVet Technology
PulseVet shock wave therapy serves as official ESWT for AQHA, NCHA, NRCHA, World Equestrian Center, US Equestrian, USEA, and USEF. That endorsement reflects 20 years of clinical research backing the technology.Â
Two decades of equine shock wave therapy research show consistent findings: no serious complications, measurable improvement rates across multiple conditions, and fewer treatments required than alternative systems. Â
*Dr. Keeton is an employee of  Zomedica Inc. and was paid for her webinar presentation. Watch the webinar here.Â
© 2025 Zomedica Inc. All rights reserved. PulseVet is a registered trademark of Zomedica Inc.Â






